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Abstract
Background: Globally, there is greater awareness of the plight of women who have 
complications associated with pregnancy or childbirth and who may continue to expe-
rience long- term problems. In addition, the health of women and their ability to per-
form economic and social functions are central to the Sustainable Development Goals.
Methods: In 2012, WHO began an initiative to standardize the definition, conceptual-
ization, and assessment of maternal morbidity. The culmination of this work was a 
conceptual framework: the Maternal Morbidity Measurement (MMM) Framework.
Results: The framework underscores the broad ramifications of maternal morbidity 
and highlights what types of measurement are needed to capture what matters to 
women, service providers, and policy makers. Using examples from the literature, we 
explain the framework’s principles and its most important elements.
Conclusions: We express the need for comprehensive research and detailed longitudi-
nal studies of women from early pregnancy to the extended postpartum period to 
understand how health and symptoms and signs of ill health change. With respect to 
interventions, there may be gaps in healthcare provision for women with chronic con-
ditions and who are about to conceive. Women also require continuity of care at the 
primary care level beyond the customary 6 weeks postpartum.
K E Y W O R D S
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1  | INTRODUCTION
Over the last 15 years, maternal mortality has declined in most parts of 
the world, although not as much as anticipated when the Millennium 
Development Goals (MDGs) were agreed to in 2000. The maternal 
morbidity burden also remains substantial, especially in comparison 
with mortality, although estimates vary. Graham et al.1 calculated, for 
example, 27 million morbidity episodes for the five most common direct 
obstetric complications alone (eclampsia, pre- eclampsia, postpartum 
hemorrhage, puerperal infection, and abortion complications) in 2015.
In view of these large numbers, there is a greater awareness at the 
global level of the plight of women who have complications associated 
with pregnancy or childbirth and who may continue to have problems 
in the long term. Fortunately, the health of women and the ability of 
women to perform economic and social functions are a central concept 
in the Sustainable Development Goals (SDGs)2 and there have been 
calls for “rethinking maternal health” using a life cycle or life- course 
approach.3 In particular, the “Survive, Thrive and Transform” agenda of 
the “Global Strategy for Women’s, Children’s and Adolescents’ Health 
(2016–2030)”4 moves away from a single focus on maternal and child 
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mortality reduction, by adding an emphasis on ensuring good health so 
that women, adolescents, and children can play their full role in future 
development.
In 2012, WHO began a program of work on the definition, con-
ceptualization, and assessment of maternal morbidity. The work aimed 
to document the various definitions of maternal morbidity and to 
develop a common approach for better understanding its magnitude. A 
Maternal Morbidity Working Group (MMWG) was established to work 
on this challenging agenda5 and focused on understanding the entire 
experience of morbidity, including non- life- threatening conditions as 
well as more severe ones. The MMWG agreed on the following defi-
nition of maternal morbidity: “any health condition attributed to and/
or complicating pregnancy and childbirth that has a negative impact 
on the woman’s wellbeing and/or functioning”.6 This work led to a 
conceptual framework, entitled the Maternal Morbidity Measurement 
(MMM) Framework, externally reviewed, and displayed in Figure 1.
2  | AIMS OF THE MMM FRAMEWORK
This conceptual framework underscores the broad ramifications of 
maternal morbidity and highlights the types of measurement that 
should take place to capture everything that matters to women, ser-
vice providers, and policy makers. The framework is also expected 
to have important implications for healthcare interventions and 
programs, which are explored in the article by Firoz et al.7 in this 
Supplement. A better understanding of maternal morbidity should, 
in due course, lead to a lesser burden as better policies are put in 
place and tailored services are provided. The novelty of the concep-
tual framework, and the associated definition of maternal morbidity, 
is that for maternal health it accounts for and applies the principles 
of the WHO International Classification of Functioning, Disability and 
Health (ICF).
3  | WHY A NEW CONCEPTUAL 
FRAMEWORK?
Despite the large numbers of estimated complications mentioned ear-
lier, there is little comprehensive research on maternal morbidity. The 
range of conditions is so large6 that studies often focus on the most 
life- threatening or debilitating causes of obstetric morbidity and/or 
on a single condition.8 The lack of comprehensiveness is not just in 
terms of conditions, but also in relation to the duration of observa-
tion. Cross- sectional surveys of self- reported symptoms of ill health 
during pregnancy or the postpartum period exist,9 but cohort studies 
that integrate both diagnoses and self- reports of ill health are rare.10 
In 1999, Fortney and Smith11 noted “the literature is replete with 
hospital- based studies, case studies and anecdotes describing acute 
and chronic morbidities with pregnancy and delivery. What does 
remain relatively unknown is the prevalence of morbidity—specific or 
general—in the population as a whole.” These remarks remain largely 
true today; little has changed in terms of morbidity evidence despite 
the increase in data on maternal health.8,12
F I G U R E  1   Maternal morbidity measurement (MMM) framework.
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The dearth of comprehensive research and data is a result of both 
difficulties with measurement approaches and a lack of systematic 
understanding of the many facets of maternal morbidity. Concerning 
measurement, in the early 1990s, researchers were initially hopeful 
that they could capture robust population- based information on direct 
obstetric morbidity in retrospective interview surveys. These attempts 
failed in low- income countries as the lack of specificity of question-
naires led to an overestimation of maternal morbidity,13 although 
some successes were registered in higher- resourced settings.14 Most 
published work on maternal morbidity has since focused on near- 
miss morbidity identified in health facilities,15,16 chronic conditions of 
importance to other medical specialties (i.e. psychiatry), and long- term 
debilitating conditions such as vesicovaginal fistulae, associated with 
the ongoing Campaign to End Fistula. The lack of rich and comprehen-
sive information is found not only in quantitative studies of maternal 
morbidity but also in qualitative ones.
The recently published literature suggests that research efforts are 
expanding their focus. There is a greater awareness of the contribution 
of chronic conditions and indirect causes of mortality to the burden 
of ill health experienced by women, most notably the contribution 
of diabetes.17 Researchers have started documenting economic and 
social consequences of maternal morbidity, and their relationship with 
productivity, economic growth, and development.18 A recent paper, fit-
tingly entitled “Minor ailments in pregnancy are not a minor concern 
for pregnant women” has shown that nine out of 10 women disclosed 
at least one episode of ill health during pregnancy in Sri Lanka and that 
60% of women could not do their day- to- day and work- related activ-
ities because of ill health.19 There is also a greater awareness of the 
importance of assessing functioning and well- being in relation to health 
conditions, including maternal complications.20,21 Health- related func-
tioning refers to all bodily functions (physical and cognitive), activities, 
and participation. It is the positive correlate of disability—a term more 
frequently used in older maternal morbidity literature. Well- being, on 
the other hand, relates to patients’ satisfaction with their health status 
and is measured with quality- of- life instruments.
4  | PREVIOUS CONCEPTUAL  
FRAMEWORKS
As mentioned earlier, the aim of the MMM Framework is to highlight 
the implications of maternal morbidity by describing its many fac-
ets in detail and promoting better measurement. Prevailing concep-
tual frameworks in maternal health have different objectives. They 
concentrate mostly on risk factors for maternal mortality and inter-
ventions to reduce it, and not particularly on the experience and con-
sequences of maternal deaths for families and communities. The most 
well- known frameworks describe the distal and intermediate deter-
minants of maternal mortality22 and the role of emergency obstet-
ric care using the popular “three delays model”.23 Other frameworks 
address the analysis of the quality of care and health systems issues 
in relation to audits of maternal deaths and severe morbidity cases.24 
While authors of these conceptual frameworks indicate that they can 
be readily applied to life- threatening conditions, they do not unpack 
the concept of morbidity, especially non- severe morbidity. Existing 
discussions or conceptual frameworks specific to maternal morbidity 
have emphasized the “base of the iceberg”25; the determinants of fis-
tulae formation, including clinical determinants26; the various stages in 
the severity of maternal morbidity (WHO); or the consequences, dis-
abilities, or sequelae attached to life- threatening morbidity for moth-
ers, babies, and households.27,28
5  | PRINCIPLES OF THE 
MMM FRAMEWORK
The MMM Framework reflects six key principles:
1. The importance of using a woman-centered approach. In other 
words, women’s perspectives on what is important to them 
regarding their health. As alluded to earlier, health problems that 
stop women from performing their normal activities may have 
substantial direct or indirect impact on their lives and on other 
members of their households. A woman-centered approach is 
also why the framework includes adverse fetal and infant out-
comes, as these can lead to an adverse maternal outcome. There 
is ample evidence, for example, that stillbirths are linked to 
psychological distress,29 and women who experience stillbirth may 
take longer than other women to recover from complications.
2. Maternal morbidity risks are cyclical since women can become 
pregnant more than once. In addition, sequelae of a maternal condi-
tion can occur in the next pregnancy. Women who deliver by cesar-
ean, for example, are at increased risk of placenta previa in 
subsequent pregnancies.30
3. The effects of maternal morbidity can last a long time, beyond the 
customary 6 weeks postpartum, and there may be consequences 
later in life, during the postreproductive or postmenopausal periods. 
For instance, women who have hypertension during pregnancy are 
more likely to suffer cardiovascular diseases at older ages.
4. Maternal health is a social and economic phenomenon, not just a 
clinical and biological issue.
5. Context and environment influence the lived experience of morbid-
ity. Living in a supportive environment can lead to better outcomes.
6. Finally, the framework includes meaningful groupings of maternal 
morbidity and has strong linkages with other WHO guidance 
(ICF; the WHO application of International Classification of 
Diseases-10 to deaths during pregnancy, childbirth and the puer-
perium: ICD Maternal Mortality [ICD-MM]; continuum of care; 
and quality of care).31–33
6  | KEY CONCEPTS IN THE CONCEPTUAL 
FRAMEWORK (SEE FIGURE 1)
As explained in the introduction, maternal morbidity first refers to 
“any health condition attributed to and/or complicating childbirth.” 
     |  7Filippi ET Al.
The categories used for the health conditions (bottom left, pink box) 
are from ICD- MM and include obstetric morbidities, medical mor-
bidities, and injuries.33 The first three categories include a total of 
121 maternal morbidity conditions as reported within the maternal 
morbidity matrix mentioned earlier.6 It is worth noting that complica-
tions associated with surgical care and medical management, includ-
ing cesarean delivery and episiotomy complications, are incorporated 
in obstetric conditions. Using these comprehensive categories and 
ICD- 10 coding to report on conditions will facilitate the consistent 
reporting and analysis of maternal morbidity diagnoses. To these we 
have added fetal/infant morbidities in view of their many negative 
linkages with maternal morbidity outcomes and maternal well- being.
The immediate outcomes of maternal conditions form a continuum 
starting with full recovery, maternal morbidity (whether short term or 
long term), potentially life- threatening conditions, maternal near miss 
(women who nearly died), or maternal deaths. While individual women 
can progress from maternal morbidity to full recovery, near miss, or death, 
retrospective reporting of the final outcomes is best done using mutually 
exclusive categories. Except for maternal death, each of these conditions 
can have a negative or, in some cases, positive impact on functioning 
and well-being of individual women. For example, life- threatening post-
partum hemorrhage and its associated impact on hemoglobin levels 
can lead to a loss of women’s productivity; whereas the loss of a baby 
will affect the psychological well- being of a mother, but can also bring a 
couple or a family closer together in facing adversity. Pregnancy, child-
birth, and the lived experience of the postnatal period may also have 
an independent impact on health, social, and economic functioning and 
well- being, whether a woman has recovered or not, but this framework 
assumes that the more severe the morbidity the higher the risk or proba-
bility of an adverse effect on functioning and well- being.34
The reproductive health cycle (represented by an ellipse) is placed 
at the center of the framework, linking the different stages of preg-
nancy, labor, and childbirth to the puerperium, and pre- reproductive 
life to the postreproductive part of the life cycle. A maternal morbidity 
can start at any time during pregnancy, childbirth, or after pregnancy, 
and it may be self- limiting, or may continue. This period is further linked 
to the women’s health status before becoming fertile (nutrition, age 
at menarche, pre- existing illnesses or disabilities) and influences the 
postreproductive and postmenopausal periods. In addition, the inter-
val between pregnancies is an important risk factor for maternal mor-
bidity for women who have more than one pregnancy. Intervals that 
are too short (5 months or less) or too long (longer than 59 months) 
have both been associated with complications.35 Ethnographic studies 
have shown the importance of fertility and reproduction to women 
and their partners, particularly in high- fertility settings; for this rea-
son, many women become pregnant again even though they might not 
have recovered from a previous pregnancy.36
External factors are at the top of the framework, represented by a 
circle with four rings, and include laws and policies, health systems and 
quality of care, the pre- existing socioeconomic status of women, and the 
health status of women. These interact with the reproductive health cycle, 
and influence women’s risks of becoming pregnant, getting unwell during 
pregnancy, and complications becoming serious or being eliminated.
The health system influences the likelihood and severity of maternal 
morbidity in the same ways that it influences the reduction of maternal 
mortality, by preventing complications and by reducing the three delays 
in: (1) deciding to seek care; (2) reaching the appropriate level of care; 
and (3) receiving the appropriate treatment. Not all conditions, signs, 
and symptoms that complicate pregnancies are potentially lethal, how-
ever, and many can be treated at the primary healthcare level, espe-
cially when they are chronic (see Firoz et al.7 in this Supplement). In 
addition, early detection of noncommunicable diseases and interven-
tions targeting lifestyle factors before conception, during pregnancy, 
and after pregnancy can prevent other adverse events for women and 
infants. Diabetes and chronic hypertension, for instance, can both 
lead to adverse outcomes during pregnancy and delivery, and are risk 
factors for increased cardiovascular diseases later in life for women.37 
This is why a life- cycle approach to women’s health care is necessary. 
The recent WHO quality- of- care model highlights the importance, to 
improve health outcomes, of evidence- based practices, information 
systems, referral systems, competent staff, and appropriate facilities, as 
well as of the perceptions of women about their care.31
Many observational studies have demonstrated that women from 
disadvantaged or poor socioeconomic backgrounds do not access 
reproductive health services at the same level as richer women38; and 
while there is very limited evidence of differences in morbidity inci-
dence risks between disadvantaged and advantaged women, research 
indicates that disadvantaged women may have more serious adverse 
pregnancy and health outcomes, such as near- miss events.39 These 
socioeconomic determinants include education,40 occupation,41 eth-
nicity,41 and wealth,39 as well as issues related to structural violence 
toward women, and the status of women in their society.
Laws that regulate women’s work such as maternity leave, and 
laws concerned with reproductive rights, including access to family 
planning and abortion, also influence both the risk of morbidity and 
the chance of recovery postpartum. Similarly, policies that invest in 
improving the social determinants of health (such as female educa-
tion) and facilitate women’s access to health care help reduce both 
the occurrence of morbidity, and improve access to treatment.2 In 
some settings, women with unintended pregnancies have been found 
to delay accessing antenatal care and to make fewer visits. There is 
also evidence, albeit mostly from high- income settings, that women 
with unintended pregnancies are also more likely to have depression 
or anxiety after childbirth.42 Finally, the ability offered by social pro-
tection to rest and recover after childbirth, particularly when there has 
been a complication, is paramount to avoiding further adversity.43
Health status refers to the underlying or contributing health 
conditions that the woman may have at the time of conception and 
pregnancy. The MMWG data collection tool documents, for example, 
self- reported violence exposure, obesity, being sexually satisfied, HIV, 
and substance abuse as well as reproductive risk factors such as age and 
parity. Using the tool, a high prevalence of obesity (antenatal: 34.9%, 
postpartum: 22.6%), sexual dissatisfaction (antenatal: 34.4%, postpar-
tum: 21.5%), and exposure to violence (antenatal: 12.8%, postpartum: 
11.0%) was found in women presenting for antenatal and postpartum 
care in Jamaica, Kenya, and Malawi.44 Sexual dissatisfaction and living in 
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urban settings were the only two remaining risk factors associated with 
maternal morbidity in a multivariate analysis using data from the three 
countries. Globally, the increase in obesity among women of reproduc-
tive age is of concern, given its association with gestational diabetes, 
pre- eclampsia, and stillbirths. Age—being particularly young or partic-
ularly old—is also important, as well as parity.41 A list of past obstetric, 
medical, and social history conditions is included in Chou et al.6
Box 1 illustrates the applicability of the framework using a real- life 
case study.
Measurement efforts and interventions to reduce maternal mor-
tality have primarily focused on the period around childbirth, skilled 
birth attendance, and emergency obstetric care. While these are still 
very relevant today, we hope that this framework will help research-
ers, providers, and policy makers recognize where the gaps in knowl-
edge on maternal morbidity exist so that comprehensive research 
is conducted and better services or policies are provided to reduce 
its burden. From a research perspective, there is an urgent need for 
detailed and comprehensive longitudinal studies of women from early 
pregnancy through the extended postpartum period, to understand 
how health and symptoms and signs of ill health change during this 
reproductive period. With respect to interventions, the framework 
suggests that there may be gaps in healthcare provision for women 
who have chronic conditions and are about to conceive. Women also 
require a continuity of care at the primary healthcare level beyond the 
customary 6 weeks postpartum. Finally, adequate social protection 
policies and laws are needed so that women can use preventive and 
curative services when they need them, and recover from illnesses 
and/or disabilities.
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